麻豆原创 Analysis and Insights: Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创
The global In Vitro Diagnostics (IVD) Quality Control Product market is projected to grow from US$ 815.3 million in 2024 to US$ 918.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for In Vitro Diagnostics (IVD) Quality Control Product market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of In Vitro Diagnostics (IVD) Quality Control Product, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for In Vitro Diagnostics (IVD) Quality Control Product, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In Vitro Diagnostics (IVD) Quality Control Product revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global In Vitro Diagnostics (IVD) Quality Control Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for In Vitro Diagnostics (IVD) Quality Control Product revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Randox Laboratories
Roche Diagnostics
Abbott Diagnostics
Helena Laboratories
Seracare Life Sciences
Technopath Clinical Diagnostics
Sun Diagnostics
Zeptometrix Corporation
ISOLAB
Sysmex Corporation
Fortress Diagnostics
Meril Life Sciences
Multiplicom
Future Diagnostics Solutions
Surmodics
Segment by Type
Quality Control Products
Quality Assurance Services
Data Management Solutions
Segment by Application
Clinical Chemistry
Immunochemistry
Hematology
Molecular Diagnostics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of In Vitro Diagnostics (IVD) Quality Control Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostics (IVD) Quality Control Product companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vitro Diagnostics (IVD) Quality Control Product revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Quality Control Products
1.2.3 Quality Assurance Services
1.2.4 Data Management Solutions
1.3 麻豆原创 by Application
1.3.1 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Clinical Chemistry
1.3.3 Immunochemistry
1.3.4 Hematology
1.3.5 Molecular Diagnostics
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Perspective (2019-2030)
2.2 Global In Vitro Diagnostics (IVD) Quality Control Product Growth Trends by Region
2.2.1 In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vitro Diagnostics (IVD) Quality Control Product Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 In Vitro Diagnostics (IVD) Quality Control Product Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Dynamics
2.3.1 In Vitro Diagnostics (IVD) Quality Control Product Industry Trends
2.3.2 In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Drivers
2.3.3 In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Challenges
2.3.4 In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue In Vitro Diagnostics (IVD) Quality Control Product by Players
3.1.1 Global In Vitro Diagnostics (IVD) Quality Control Product Revenue by Players (2019-2024)
3.1.2 Global In Vitro Diagnostics (IVD) Quality Control Product Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of In Vitro Diagnostics (IVD) Quality Control Product, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Concentration Ratio
3.4.1 Global In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVD) Quality Control Product Revenue in 2023
3.5 Global Key Players of In Vitro Diagnostics (IVD) Quality Control Product Head office and Area Served
3.6 Global Key Players of In Vitro Diagnostics (IVD) Quality Control Product, Product and Application
3.7 Global Key Players of In Vitro Diagnostics (IVD) Quality Control Product, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostics (IVD) Quality Control Product Breakdown Data by Type
4.1 Global In Vitro Diagnostics (IVD) Quality Control Product Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global In Vitro Diagnostics (IVD) Quality Control Product Forecasted 麻豆原创 Size by Type (2025-2030)
5 In Vitro Diagnostics (IVD) Quality Control Product Breakdown Data by Application
5.1 Global In Vitro Diagnostics (IVD) Quality Control Product Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global In Vitro Diagnostics (IVD) Quality Control Product Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2019-2030)
6.2 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type
6.2.1 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2019-2024)
6.2.2 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2025-2030)
6.2.3 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Type (2019-2030)
6.3 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application
6.3.1 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2019-2024)
6.3.2 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2025-2030)
6.3.3 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Application (2019-2030)
6.4 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country
6.4.1 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2019-2024)
6.4.3 North America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2019-2030)
7.2 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type
7.2.1 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Type (2019-2030)
7.3 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application
7.3.1 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Application (2019-2030)
7.4 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country
7.4.1 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2019-2030)
8.2 China In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type
8.2.1 China In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2019-2024)
8.2.2 China In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2025-2030)
8.2.3 China In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Type (2019-2030)
8.3 China In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application
8.3.1 China In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2019-2024)
8.3.2 China In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2025-2030)
8.3.3 China In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2019-2030)
9.2 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type
9.2.1 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Type (2019-2030)
9.3 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application
9.3.1 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Application (2019-2030)
9.4 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Region
9.4.1 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America In Vitro Diagnostics (IVD) Quality Control Product 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Details
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.1.4 Bio-Rad Laboratories Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.1.5 Bio-Rad Laboratories Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.2.4 Thermo Fisher Scientific Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Randox Laboratories
11.3.1 Randox Laboratories Company Details
11.3.2 Randox Laboratories Business Overview
11.3.3 Randox Laboratories In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.3.4 Randox Laboratories Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.3.5 Randox Laboratories Recent Developments
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Details
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.4.4 Roche Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.4.5 Roche Diagnostics Recent Developments
11.5 Abbott Diagnostics
11.5.1 Abbott Diagnostics Company Details
11.5.2 Abbott Diagnostics Business Overview
11.5.3 Abbott Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.5.4 Abbott Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.5.5 Abbott Diagnostics Recent Developments
11.6 Helena Laboratories
11.6.1 Helena Laboratories Company Details
11.6.2 Helena Laboratories Business Overview
11.6.3 Helena Laboratories In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.6.4 Helena Laboratories Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.6.5 Helena Laboratories Recent Developments
11.7 Seracare Life Sciences
11.7.1 Seracare Life Sciences Company Details
11.7.2 Seracare Life Sciences Business Overview
11.7.3 Seracare Life Sciences In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.7.4 Seracare Life Sciences Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.7.5 Seracare Life Sciences Recent Developments
11.8 Technopath Clinical Diagnostics
11.8.1 Technopath Clinical Diagnostics Company Details
11.8.2 Technopath Clinical Diagnostics Business Overview
11.8.3 Technopath Clinical Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.8.4 Technopath Clinical Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.8.5 Technopath Clinical Diagnostics Recent Developments
11.9 Sun Diagnostics
11.9.1 Sun Diagnostics Company Details
11.9.2 Sun Diagnostics Business Overview
11.9.3 Sun Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.9.4 Sun Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.9.5 Sun Diagnostics Recent Developments
11.10 Zeptometrix Corporation
11.10.1 Zeptometrix Corporation Company Details
11.10.2 Zeptometrix Corporation Business Overview
11.10.3 Zeptometrix Corporation In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.10.4 Zeptometrix Corporation Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.10.5 Zeptometrix Corporation Recent Developments
11.11 ISOLAB
11.11.1 ISOLAB Company Details
11.11.2 ISOLAB Business Overview
11.11.3 ISOLAB In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.11.4 ISOLAB Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.11.5 ISOLAB Recent Developments
11.12 Sysmex Corporation
11.12.1 Sysmex Corporation Company Details
11.12.2 Sysmex Corporation Business Overview
11.12.3 Sysmex Corporation In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.12.4 Sysmex Corporation Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.12.5 Sysmex Corporation Recent Developments
11.13 Fortress Diagnostics
11.13.1 Fortress Diagnostics Company Details
11.13.2 Fortress Diagnostics Business Overview
11.13.3 Fortress Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.13.4 Fortress Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.13.5 Fortress Diagnostics Recent Developments
11.14 Meril Life Sciences
11.14.1 Meril Life Sciences Company Details
11.14.2 Meril Life Sciences Business Overview
11.14.3 Meril Life Sciences In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.14.4 Meril Life Sciences Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.14.5 Meril Life Sciences Recent Developments
11.15 Multiplicom
11.15.1 Multiplicom Company Details
11.15.2 Multiplicom Business Overview
11.15.3 Multiplicom In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.15.4 Multiplicom Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.15.5 Multiplicom Recent Developments
11.16 Future Diagnostics Solutions
11.16.1 Future Diagnostics Solutions Company Details
11.16.2 Future Diagnostics Solutions Business Overview
11.16.3 Future Diagnostics Solutions In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.16.4 Future Diagnostics Solutions Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.16.5 Future Diagnostics Solutions Recent Developments
11.17 Surmodics
11.17.1 Surmodics Company Details
11.17.2 Surmodics Business Overview
11.17.3 Surmodics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.17.4 Surmodics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.17.5 Surmodics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bio-Rad Laboratories
Thermo Fisher Scientific
Randox Laboratories
Roche Diagnostics
Abbott Diagnostics
Helena Laboratories
Seracare Life Sciences
Technopath Clinical Diagnostics
Sun Diagnostics
Zeptometrix Corporation
ISOLAB
Sysmex Corporation
Fortress Diagnostics
Meril Life Sciences
Multiplicom
Future Diagnostics Solutions
Surmodics
听
听
*If Applicable.
